» Articles » PMID: 8896446

A Novel Membrane Receptor with High Affinity for Lysosphingomyelin and Sphingosine 1-phosphate in Atrial Myocytes

Overview
Journal EMBO J
Date 1996 Oct 15
PMID 8896446
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of IK(ACh) is the major effect of the vagal neutrotransmitter acetylcholine in the heart. We report that both lysosphingomyelin (D-erythro-sphingosyl-phosphorylcholine; SPC) and sphingosine 1-phosphate (SPP) activate IK(ACh) in guinea pig atrial myocytes through the same receptor with an EC50 of 1.5 and 1.2 nM, respectively. Pertussis toxin abolished the activation of IK(ACh) by either lipid. The putative receptor showed an exquisite stereoselectivity for the naturally occurring D-erythro-(2S,3R)-SPC stereoisomer, the structure of which was confirmed by mass spectroscopy and NMR. These lipids caused complete homologous and heterologous desensitization with each other but not with ACh, indicating that both act on the same receptor. This receptor displays a distinct structure-activity relationship: it requires an unsubstituted amino group because N-acetyl-SPC, lysophosphatidic acid and lysophosphatidylcholine were inactive. Because SPP and SPC are naturally occurring products of membrane lipid metabolism, it appears that these compounds might be important extracellular mediators acting on a family of bona fide G protein-coupled receptors. Expression of these receptors in the heart raises the possibility that sphingolipids may be a part of the physiological and/or pathophysiological regulation of the heart. Based on their ligand selectivity we propose a classification of the sphingolipid receptors.

Citing Articles

Differential Modulation of and Channels in High-Fat Diet-Induced Obese Guinea Pig Atria.

Martinez-Mateu L, Saiz J, Aromolaran A Front Physiol. 2019; 10:1212.

PMID: 31607952 PMC: 6773813. DOI: 10.3389/fphys.2019.01212.


Differential effects of lysophosphatidylcholine and ACh on muscarinic K(+),non-selective cation and Ca(2+) currents in guinea-pig atrial cells.

Li L, Matsuoka I, Sakamoto K, Kimura J Fukushima J Med Sci. 2016; 62(1):27-35.

PMID: 26911304 PMC: 5131578. DOI: 10.5387/fms.2015-23.


Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde.

Takuwa N, Du W, Kaneko E, Okamoto Y, Yoshioka K, Takuwa Y Am J Cancer Res. 2011; 1(4):460-81.

PMID: 21984966 PMC: 3186046.


Dissociation of calmodulin-target peptide complexes by the lipid mediator sphingosylphosphorylcholine: implications in calcium signaling.

Kovacs E, Toth J, Vertessy B, Liliom K J Biol Chem. 2009; 285(3):1799-808.

PMID: 19910470 PMC: 2804338. DOI: 10.1074/jbc.M109.053116.


Sphingosine-1-phosphate receptor signalling in the heart.

Means C, Brown J Cardiovasc Res. 2009; 82(2):193-200.

PMID: 19282351 PMC: 2721649. DOI: 10.1093/cvr/cvp086.


References
1.
Karlsson K . On the chemistry and occurrence of sphingolipid long-chain bases. Chem Phys Lipids. 1970; 5(1):6-43. DOI: 10.1016/0009-3084(70)90008-3. View

2.
GAVER R, Sweeley C . METHODS FOR METHANOLYSIS OF SPHINGOLIPIDS AND DIRECT DETERMINATION OF LONG-CHAIN BASES BY GAS CHROMATOGRAPHY. J Am Oil Chem Soc. 1965; 42:294-8. DOI: 10.1007/BF02540132. View

3.
Wykle R, Miller C, Lewis J, SCHMITT J, Smith J, Surles J . Stereospecific activity of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine and comparison of analogs in the degranulation of platelets and neutrophils. Biochem Biophys Res Commun. 1981; 100(4):1651-8. DOI: 10.1016/0006-291x(81)90708-7. View

4.
Cohen R, Barenholz Y, Gatt S, Dagan A . Preparation and characterization of well defined D-erythro sphingomyelins. Chem Phys Lipids. 1984; 35(4):371-84. DOI: 10.1016/0009-3084(84)90079-3. View

5.
Hannun Y, Bell R . Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science. 1987; 235(4789):670-4. DOI: 10.1126/science.3101176. View